カテゴリー： Market Monitor Global, 世界, 医療/バイオ

急性リンパ性白血病治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Acute Lymphocytic Leukemia Therapeutics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5626）◆商品コード：MMG23JU5626
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：65
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Acute Lymphocytic Leukemia Therapeutics Market 調査レポートは次の情報を含め、グローバルにおけるの急性リンパ性白血病治療薬市場規模と予測を収録しています。・世界の急性リンパ性白血病治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の急性リンパ性白血病治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の急性リンパ性白血病治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口投与」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

急性リンパ性白血病治療薬のグローバル主要企業は、Erytech Pharma、 Talon Therapeutic, Inc、 Glaxosmithkline Plc、 Sigma-tau Pharmaceuticals, Inc、 Genzyme Corporation、 Amgen、 Bristol-myers Squibb、 Novartis、 Juno Therapeutics, Inc.、 Celgene Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、急性リンパ性白血病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の急性リンパ性白血病治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の急性リンパ性白血病治療薬市場：タイプ別市場シェア、2022年
・経口投与、非経口投与

世界の急性リンパ性白血病治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の急性リンパ性白血病治療薬市場：用途別市場シェア、2022年
・大人、子供

世界の急性リンパ性白血病治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の急性リンパ性白血病治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における急性リンパ性白血病治療薬のグローバル売上、2018年-2023年
・主要企業における急性リンパ性白血病治療薬のグローバル売上シェア、2022年
・主要企業における急性リンパ性白血病治療薬のグローバル販売量、2018年-2023年
・主要企業における急性リンパ性白血病治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Erytech Pharma、 Talon Therapeutic, Inc、 Glaxosmithkline Plc、 Sigma-tau Pharmaceuticals, Inc、 Genzyme Corporation、 Amgen、 Bristol-myers Squibb、 Novartis、 Juno Therapeutics, Inc.、 Celgene Corporation

*************************************************************

・調査・分析レポートの概要
急性リンパ性白血病治療薬市場の定義
市場セグメント
世界の急性リンパ性白血病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の急性リンパ性白血病治療薬市場規模
世界の急性リンパ性白血病治療薬市場規模：2022年 VS 2029年
世界の急性リンパ性白血病治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの急性リンパ性白血病治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の急性リンパ性白血病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口投与、非経口投与
急性リンパ性白血病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
急性リンパ性白血病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別急性リンパ性白血病治療薬市場規模 2022年と2029年
地域別急性リンパ性白血病治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Erytech Pharma、 Talon Therapeutic, Inc、 Glaxosmithkline Plc、 Sigma-tau Pharmaceuticals, Inc、 Genzyme Corporation、 Amgen、 Bristol-myers Squibb、 Novartis、 Juno Therapeutics, Inc.、 Celgene Corporation
...

Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called as lymphocytes in bone marrow. It is a malignant disease in which early precursor lymphoid cells proliferate and replace the normal hematopoietic cells of bone marrow. ALL is the most common type of cancer in children. There is overproduction of lymphoblasts in the bone marrow when a person suffers from ALL that continuously multiply, damaging the bone marrow by preventing the production of normal cells such as red blood cells (RBC) and platelets. Increase in number of lymphoblast in the blood results in the decline of healthy RBCs, white blood cells, and platelets. This leads to anemia, bleeding, and infection. The cancer can spread to the spinal cord and the brain.
This report aims to provide a comprehensive presentation of the global market for Acute Lymphocytic Leukemia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Lymphocytic Leukemia Therapeutics. This report contains market size and forecasts of Acute Lymphocytic Leukemia Therapeutics in global, including the following market information:
Global Acute Lymphocytic Leukemia Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Acute Lymphocytic Leukemia Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Administration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Lymphocytic Leukemia Therapeutics include Erytech Pharma, Talon Therapeutic, Inc, Glaxosmithkline Plc, Sigma-tau Pharmaceuticals, Inc, Genzyme Corporation, Amgen, Bristol-myers Squibb, Novartis and Juno Therapeutics, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Lymphocytic Leukemia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Lymphocytic Leukemia Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Acute Lymphocytic Leukemia Therapeutics Market Segment Percentages, by Type, 2022 (%)
Oral Administration
Parental Administration
Global Acute Lymphocytic Leukemia Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Acute Lymphocytic Leukemia Therapeutics Market Segment Percentages, by Application, 2022 (%)
Adult
Children
Global Acute Lymphocytic Leukemia Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Acute Lymphocytic Leukemia Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Lymphocytic Leukemia Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Lymphocytic Leukemia Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Erytech Pharma
Talon Therapeutic, Inc
Glaxosmithkline Plc
Sigma-tau Pharmaceuticals, Inc
Genzyme Corporation
Amgen
Bristol-myers Squibb
Novartis
Juno Therapeutics, Inc.
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Lymphocytic Leukemia Therapeutics, market overview.
Chapter 2: Global Acute Lymphocytic Leukemia Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Acute Lymphocytic Leukemia Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Lymphocytic Leukemia Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Acute Lymphocytic Leukemia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Lymphocytic Leukemia Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Lymphocytic Leukemia Therapeutics Overall Market Size
2.1 Global Acute Lymphocytic Leukemia Therapeutics Market Size: 2022 VS 2029
2.2 Global Acute Lymphocytic Leukemia Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Lymphocytic Leukemia Therapeutics Players in Global Market
3.2 Top Global Acute Lymphocytic Leukemia Therapeutics Companies Ranked by Revenue
3.3 Global Acute Lymphocytic Leukemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Lymphocytic Leukemia Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Lymphocytic Leukemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Lymphocytic Leukemia Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Acute Lymphocytic Leukemia Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Lymphocytic Leukemia Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Acute Lymphocytic Leukemia Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Oral Administration
4.1.3 Parental Administration
4.2 By Type – Global Acute Lymphocytic Leukemia Therapeutics Revenue & Forecasts
4.2.1 By Type – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2023
4.2.2 By Type – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2024-2029
4.2.3 By Type – Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acute Lymphocytic Leukemia Therapeutics Market Size, 2022 & 2029
5.1.2 Adult
5.1.3 Children
5.2 By Application – Global Acute Lymphocytic Leukemia Therapeutics Revenue & Forecasts
5.2.1 By Application – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2023
5.2.2 By Application – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2024-2029
5.2.3 By Application – Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Acute Lymphocytic Leukemia Therapeutics Market Size, 2022 & 2029
6.2 By Region – Global Acute Lymphocytic Leukemia Therapeutics Revenue & Forecasts
6.2.1 By Region – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2023
6.2.2 By Region – Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2024-2029
6.2.3 By Region – Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029
6.3.2 US Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.3.3 Canada Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.3.4 Mexico Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029
6.4.2 Germany Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.3 France Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.4 U.K. Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.5 Italy Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.6 Russia Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.4.8 Benelux Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029
6.5.2 China Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.5.3 Japan Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.5.4 South Korea Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.5.6 India Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029
6.6.2 Brazil Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.6.3 Argentina Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029
6.7.2 Turkey Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.7.3 Israel Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
6.7.5 UAE Acute Lymphocytic Leukemia Therapeutics Market Size, 2018-2029
7 Acute Lymphocytic Leukemia Therapeutics Companies Profiles
7.1 Erytech Pharma
7.1.1 Erytech Pharma Company Summary
7.1.2 Erytech Pharma Business Overview
7.1.3 Erytech Pharma Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.1.4 Erytech Pharma Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Erytech Pharma Key News & Latest Developments
7.2 Talon Therapeutic, Inc
7.2.1 Talon Therapeutic, Inc Company Summary
7.2.2 Talon Therapeutic, Inc Business Overview
7.2.3 Talon Therapeutic, Inc Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.2.4 Talon Therapeutic, Inc Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Talon Therapeutic, Inc Key News & Latest Developments
7.3 Glaxosmithkline Plc
7.3.1 Glaxosmithkline Plc Company Summary
7.3.2 Glaxosmithkline Plc Business Overview
7.3.3 Glaxosmithkline Plc Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.3.4 Glaxosmithkline Plc Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Glaxosmithkline Plc Key News & Latest Developments
7.4 Sigma-tau Pharmaceuticals, Inc
7.4.1 Sigma-tau Pharmaceuticals, Inc Company Summary
7.4.2 Sigma-tau Pharmaceuticals, Inc Business Overview
7.4.3 Sigma-tau Pharmaceuticals, Inc Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.4.4 Sigma-tau Pharmaceuticals, Inc Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Sigma-tau Pharmaceuticals, Inc Key News & Latest Developments
7.5 Genzyme Corporation
7.5.1 Genzyme Corporation Company Summary
7.5.2 Genzyme Corporation Business Overview
7.5.3 Genzyme Corporation Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.5.4 Genzyme Corporation Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Genzyme Corporation Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.6.4 Amgen Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Bristol-myers Squibb
7.7.1 Bristol-myers Squibb Company Summary
7.7.2 Bristol-myers Squibb Business Overview
7.7.3 Bristol-myers Squibb Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.7.4 Bristol-myers Squibb Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bristol-myers Squibb Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.8.4 Novartis Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Juno Therapeutics, Inc.
7.9.1 Juno Therapeutics, Inc. Company Summary
7.9.2 Juno Therapeutics, Inc. Business Overview
7.9.3 Juno Therapeutics, Inc. Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.9.4 Juno Therapeutics, Inc. Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Juno Therapeutics, Inc. Key News & Latest Developments
7.10 Celgene Corporation
7.10.1 Celgene Corporation Company Summary
7.10.2 Celgene Corporation Business Overview
7.10.3 Celgene Corporation Acute Lymphocytic Leukemia Therapeutics Major Product Offerings
7.10.4 Celgene Corporation Acute Lymphocytic Leukemia Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Celgene Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Acute Lymphocytic Leukemia Therapeutics Market Opportunities & Trends in Global Market
Table 2. Acute Lymphocytic Leukemia Therapeutics Market Drivers in Global Market
Table 3. Acute Lymphocytic Leukemia Therapeutics Market Restraints in Global Market
Table 4. Key Players of Acute Lymphocytic Leukemia Therapeutics in Global Market
Table 5. Top Acute Lymphocytic Leukemia Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Lymphocytic Leukemia Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Lymphocytic Leukemia Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Lymphocytic Leukemia Therapeutics Product Type
Table 9. List of Global Tier 1 Acute Lymphocytic Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Lymphocytic Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Acute Lymphocytic Leukemia Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Lymphocytic Leukemia Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Acute Lymphocytic Leukemia Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Lymphocytic Leukemia Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Erytech Pharma Company Summary
Table 31. Erytech Pharma Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 32. Erytech Pharma Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Erytech Pharma Key News & Latest Developments
Table 34. Talon Therapeutic, Inc Company Summary
Table 35. Talon Therapeutic, Inc Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 36. Talon Therapeutic, Inc Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Talon Therapeutic, Inc Key News & Latest Developments
Table 38. Glaxosmithkline Plc Company Summary
Table 39. Glaxosmithkline Plc Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 40. Glaxosmithkline Plc Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Glaxosmithkline Plc Key News & Latest Developments
Table 42. Sigma-tau Pharmaceuticals, Inc Company Summary
Table 43. Sigma-tau Pharmaceuticals, Inc Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 44. Sigma-tau Pharmaceuticals, Inc Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Sigma-tau Pharmaceuticals, Inc Key News & Latest Developments
Table 46. Genzyme Corporation Company Summary
Table 47. Genzyme Corporation Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 48. Genzyme Corporation Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Genzyme Corporation Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 52. Amgen Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Bristol-myers Squibb Company Summary
Table 55. Bristol-myers Squibb Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 56. Bristol-myers Squibb Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-myers Squibb Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 60. Novartis Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Juno Therapeutics, Inc. Company Summary
Table 63. Juno Therapeutics, Inc. Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 64. Juno Therapeutics, Inc. Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Juno Therapeutics, Inc. Key News & Latest Developments
Table 66. Celgene Corporation Company Summary
Table 67. Celgene Corporation Acute Lymphocytic Leukemia Therapeutics Product Offerings
Table 68. Celgene Corporation Acute Lymphocytic Leukemia Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Celgene Corporation Key News & Latest Developments
List of Figures
Figure 1. Acute Lymphocytic Leukemia Therapeutics Segment by Type in 2022
Figure 2. Acute Lymphocytic Leukemia Therapeutics Segment by Application in 2022
Figure 3. Global Acute Lymphocytic Leukemia Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Lymphocytic Leukemia Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Lymphocytic Leukemia Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Lymphocytic Leukemia Therapeutics Revenue in 2022
Figure 8. By Type - Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Acute Lymphocytic Leukemia Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Acute Lymphocytic Leukemia Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Erytech Pharma Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Talon Therapeutic, Inc Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Glaxosmithkline Plc Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sigma-tau Pharmaceuticals, Inc Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genzyme Corporation Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-myers Squibb Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Juno Therapeutics, Inc. Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Celgene Corporation Acute Lymphocytic Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 急性リンパ性白血病治療薬の世界市場見通し2023年-2029年(Acute Lymphocytic Leukemia Therapeutics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

※関連リサーチレポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆